Literature DB >> 24177321

Design of hybrid multimodal poly(lactic-co-glycolic acid) polymer nanoparticles for neutrophil labeling, imaging and tracking.

Yuan Qiu1, Raghavendra Palankar, María Echeverría, Nikolay Medvedev, Sergio E Moya, Mihaela Delcea.   

Abstract

Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) incorporating quantum dots (QDs), superparamagnetic iron oxide nanoparticles (SPIONs) and gold (Au) NPs for neutrophil labeling were fabricated via the w/o/w double emulsion method. QDs and SPIONs were entrapped in the PLGA core during emulsification while Au NPs were assembled on top of the PLGA NPs via electrostatic interactions. Transmission Electron Microscopy, Scanning Electron Microscopy and Confocal Scanning Laser Microscopy (CLSM) were applied to characterize the hybrid PLGA NPs. The uptake of the hybrid PLGA NPs by human neutrophils was studied by Flow Cytometry and confocal microscopy. In addition, the induction of reactive oxygen species (ROS) in neutrophils after incubation with the hybrid PLGA NPs was assessed. Magnetophoresis experiments showed that neutrophils with internalized hybrid PLGA NPs can be effectively laterally displaced towards the magnetic field. Magnetic Resonance Imaging of the hybrid PLGA NPs resulted in images with a contrast enhancement linearly dependent on the concentration of the hybrid PLGA NPs. Research reported in this work is relevant for imaging, tracking and manipulating neutrophils and has potential for in vivo applications, e.g., tumor visualization and localized photothermal treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24177321     DOI: 10.1039/c3nr04013e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  8 in total

Review 1.  Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking.

Authors:  Erik M Shapiro
Journal:  Magn Reson Med       Date:  2014-04-21       Impact factor: 4.668

2.  Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation.

Authors:  Eiji Saito; Robert Kuo; Ryan M Pearson; Nishant Gohel; Brandon Cheung; Nicholas J C King; Stephen D Miller; Lonnie D Shea
Journal:  J Control Release       Date:  2019-02-27       Impact factor: 9.776

3.  A simple approach to obtain hybrid Au-loaded polymeric nanoparticles with a tunable metal load.

Authors:  Edurne Luque-Michel; Ane Larrea; Celia Lahuerta; Víctor Sebastian; Edurne Imbuluzqueta; Manuel Arruebo; María J Blanco-Prieto; Jesús Santamaría
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

4.  Gold nanorod-based poly(lactic-co-glycolic acid) with manganese dioxide core-shell structured multifunctional nanoplatform for cancer theranostic applications.

Authors:  Lei Wang; Dong Li; Yongwei Hao; Mengya Niu; Yujie Hu; Hongjuan Zhao; Junbiao Chang; Zhenzhong Zhang; Yun Zhang
Journal:  Int J Nanomedicine       Date:  2017-04-13

5.  Facile Hydrophobication of Glutathione-Protected Gold Nanoclusters and Encapsulation into Poly(lactide-co-glycolide) Nanocarriers.

Authors:  Alaaldin M Alkilany; Shrouq Alsotari; Mahmoud Y Alkawareek; Samer R Abulateefeh
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

6.  Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke.

Authors:  Yanxin Dang; Chiying An; Yutao Li; Dandan Han; Xin Liu; Fengming Zhang; Yuan Xu; Haijing Zhong; Mewand Khan Karim Khan; Fengjuan Zou; Xiaojun Sun
Journal:  RSC Adv       Date:  2019-01-10       Impact factor: 4.036

7.  Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.

Authors:  Chun Zhang; Cheng-Li Ling; Liang Pang; Qi Wang; Jing-Xin Liu; Bing-Shan Wang; Jian-Ming Liang; Yi-Zhen Guo; Jing Qin; Jian-Xin Wang
Journal:  Theranostics       Date:  2017-07-23       Impact factor: 11.556

8.  Drug discovery and formulation development for acute pancreatitis.

Authors:  Xue Jiang; Ya-Wen Zheng; Shihui Bao; Hailin Zhang; Ruijie Chen; Qing Yao; Longfa Kou
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.